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The curious success of the fetus as an allograft 
remains a mystery despite years of research. The mechanisms 
by which it avoids the inevitable immunologic attack and 
rejection expected for any genetically non-identical, 
histo-incompatible, or "non-self" tissue in close proximity 
with the host are as yet unclear. The sophistication of a 
system which can permit the gestation of even inter-species 
pregnancies (mules, ligers) yet leave the mother immunocompetent 
towards the challege of infection or attempts at other allografts 
is truly remarkable. 
A large literature dealing with this subject has been 
developed over the years, partly, it seems, from a fascin¬ 
ation over this clear exception to a rule of nature, and 
partly because of the widespread applications to clinical 
medicine which might be realized by an understanding of 
this phenomenon. Could the mechanisms be harnessed, the 
applications in organ transplant without generalized 
immunosuppression are obvious. Could the mechanisms be 
understood, they might well provide some insight into the 
success of cancerous cells, which invade normal tissues 
with immunologic impunity despite metamorphosed, and 




There is also some evidence that defects in, or side 
effects of the immunologic protection of the fetus may 
play an active role in clinical obstetrics. Indeed, the 
empiric or symptomatic treatments standard for such common 
obstetric problems as certain types of infertility, 
toxemia, and certain post partum complications may in 
fact be ineffectual or in some cases counterproductive when 
considered in light of current immunologic theory. 
Unfortunately, human pregnancy does not lend itself 
well to laboratory investigation and clinical intervention 
for obvious moral and medico-legal reasons. There is a 
paucity of appropriate animal models of human pregnancy 
for immunologic study as few species produce a hemochorial 
placenta (maternal blood in direct contact with placental 
chorion). Non-mammals do not face the same immunologic 
dilemmas. Extensive knowledge of identifiable surface 
antigens is vital to the evaluation of inter-strain preg¬ 
nancies. For the above reasons, almost all work in the 
field has been done with mice, which unfortunately do not 
suffer from certain complications of pregnancy thought to 
have immunologic bases. 
In the sphere of human investigation, certain patients 
on pharmacologic immunosuppression because of other disease 
processes provide a model for study complicated, however, 
by the very disease processes for which treatment was 
instituted. Experiments of nature in patients with congenital 
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immune deficiency states are sparse as these patients, because 
of chronic illness and early death, rarely if ever become 
pregnant. 
This paper will attempt to review the literature regarding 
altered immunologic function during pregnancy and theories 
of the physical, chemical and immunologic factors responsible, 
both those of historical interest and those of current validity. 
Finally, a consideration of several problems in clinical 
obstetrics for which there is evidence of immunologic 
participation will be presented, and possible modifications 
in therapy based on these suppositions will be suggested. 
A familiarity with the basic processes of gestation 
will be assumed. 
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To protect itself from immunologic attack by the host, 
the feto-placental unit may utilize either, or both, of two 
strategies. The first is to prevent the sensitization of 
host’s cellular and humoral immune systems by preventing 
contact between its tissue antigens and the host’s blood¬ 
stream and lymphatic components. Failing that, the feto¬ 
placental unit must must defend itself against, or defuse 
any attacks launched. The methods used by the conceptus for 
the achievement of these ends may for the purpose of 
discussion be loosely divided into mechanical, hormonal/ 
chemical, and purely immunologic mechanisms. Ideally, the 
placenta, while maintaining adequate contact with the mother 
for physiologic and nutritional support, would provide 
barriers to the infiltration of the fetus by maternal 
lymphocytes, avoiding the development of humoral antibodies 
and colonies of sensitized T cells, barriers to any anti- 
fetal antibodies which might develop, and barriers to 
prevent the escape of fetal or placental particles into the 
maternal circulation. 
In the crudest of experiments—that of depriving 
the fetus of the barrier of the placenta by the surgical 
establishment of direct anastomoses between maternal and 
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fetal circulations in inbred and outbred rabbits—there was 
no difference in survival between the allogenic and syngenic 
fetuses. Unfortunately from the point of view of the 
immunologist experimenters, all fetuses succumbed to a 
plethoric condition thought to be due to hemodynamic disturb¬ 
ances resulting from increased pressures in the maternal 
circulation being transmitted to the delicate fetal circu¬ 
lation. However, the experiment was of interest in that 
the outbred fetuses showed no evidence of acute immunologic 
attack in the roughly eighty hours before the hyperemic 
death ensued. (Scott et al, .1973) 
For years, the zona pellucida was thought to represent 
a sturdy mechanical barrier against immunologic attack in 
the pre-implantation stages of development. However, current 
standard techniques in embryo transfer involving the enzymatic 
removal of the zona demonstrate no compromise in implantation 
success even in third party, unrelated foster mothers. 
The process of implantation includes the formation 
of a decidual response at the site of initial blastocyst 
attachment. It is a mass of fibrous connective tissue 
in which the cells are linked by tight junctions which 
surrounds the site of implantation. Various hypothetical 
roles have been assigned it—the possible initial channel 
for nourishing the blastocyst, as the cells appear metabol- 
ically very active on electron microscopy (Finn, .1971), 
a protective response ellicited in the uterus to prevent 
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invasion by an agressive trophoblast, or a protective reaction 
induced in some fashion by the blastocyst for shielding 
itself from maternal lymphocytes and the development of 
maternal lymphatics at the site of attachment. The lymphatic 
theory was given some strength by the discoveries that decidual 
tissue gives no protection to model fetuses (intrauterine 
allogenic skin grafts) when the host has been pre-immunized 
against the antigens of the graft tissue, (Beer et ,al;^ . ^_ 
1975) and lymphatic-free pedicles enhance graft survival (WUstrack,etal,1975). 
Certain new evidence has come to light involving the 
roles of estrogen, histamine, and a possible contribution 
of the maternal immune system in the establishment of a 
deciduoma in the rodent. Given the data that various stimuli 
including the presence of the blastocyst, local minor trauma, 
local application of estrogens, and local application of 
histamine (De Feo, 1962), that local trauma and estrogen 
application may cau.se histamine release (Spaziani and szego, 
1959), that decidualization may be blocked by antihistamines 
(Shelesnyak, 1952), that the preimplantation blastocyst has 
been found to contain substantial amounts of estrogenic 
compounds (Borland, et al, 1977), and that uteri depleted 
histamine releasing mast cells by freezing do not produce 
deciduomata and do not implant blastocysts (Ferrando and 
Nalbandov, 1968), it might be hypothesized that the blasto¬ 
cyst, either by antigenic stimulation of a localized 
"anaphylaxis" with resulting histamine release, or by local 
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release of estrogens resulting in mast cell degranulation 
and histamine release, might cause the induction of decidual 
formation. Carrying this hypothesis further, though perhaps 
to an innappropriate degree, it might be hypothesized that 
a genetically foreign blastocyst, by exciting a larger 
decidual response, might pave the way for the larger placenta 
typically seen in cross-strain matings (see below). 
Another mechanical means by which the conceptus may 
be immunologically shielded is the glycocalyx, a layer of 
highly sulfated sialomucin lying between trophoblast and 
uterine endometrium, (Bradbury, et al, 1969). This might 
work by three mechanisms: as a physical barrier preventing 
pieces of trophoblast from washing off into the maternal 
circulation and activating the maternal immune system 
(though there is much evidence that pieces do escape, 
lodging in the lung and being destroyed there by mechanisms 
which are not entirely clear), (Atwood and Park, 1961), 
as* a highly negatively charged electrostatic barrier to 
the negatively charged maternal lymphocytes patrolling the 
area, (Currie and Bagshawe, 1967), or by the direct masking 
of surface antigens, demonstrated perhaps by the fact that 
attack of the mucopolysaccharide coat of trophoblast cells 
with neuraminidase results in the expression of strong 
histocompatibility antigens of transplantation (Currie, et 
al, 1968). The antigenicity of the trophoblast will be 
discussed further below. 
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Various hormonal substances have been hypothesized to 
act as generalized immunosuppressants in the maternal 
corculation. Blood levels of adrenal cortex hormones may 
be minimally elevated during pregnancy, but not to a suffi¬ 
cient degree to explain the success of an allograft. There 
is no evidence that corticosteroid-like substances are 
produced locally by the trophoblast producing higher 
concentrations which might be therapeutic. The immunosuppres¬ 
sive role of elevated blood levels of estrogens and proges- 
terones have also been questioned, and the delay of first 
and second set skin allograft rejection by high doses of 
estradiol has been demonstrated, though progesterone proved 
ineffective (Simmons, et al, 1968). Once again however, the 
relatively low ievcis^im pregnancy make this doubtful in 
importance as an immunosuppressive factor. 
Although there is some evidence of a degree of de¬ 
pressed maternal immunocompetence during pregnancy as 
evidenced by increased susceptibility to certain viral and 
bacterial pathogenic organisms, (St. Hill, et al, 1972), 
the existence of a locally immunosuppressive compound 
situated at the maternal-placental junction would seem 
more advantageous to the host. A prime candidate for this 
role is human chorionic gonadotriphin (HCG), a product of 
pregnancy produced by the syncytiotrophoblast in large 
quantities at the junction between the trophoblast and the 
maternal circulation, producing a blood level peak during 
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the first trimester. Its role in reproduction remains a 
mystery, however, HCG has been show to inhibit in vitro, 
both PHA induced transformation of lymphocytes (Contractors* Davies 1973) 
and the mixed lymphocyte reaction (Jenkins, et al, 1972) 
at concentrations approximating the blood levels encountered 
at the peak of production in the first trimester, and of 
course should a local mechanism be postulated, the exper¬ 
imental levels would be far exceeded at the trophoblast 
itself. 
The phenomenal success of choriocarcinoma, a malignant 
neoplasm of placental origin producing huge quantities of 
HCG and evoking no "foreign body" reaction in host tissues 
is an excellent experiment of nature in the evaluation of 
this problem. It is interesting to postulate reasons for 
the success of methotrexate therapy in this disease, as this 
drug cannot be said to be curative or achieve nearly total 
cell kill in any other malignancy. Perhaps instead of 
direct cytotoxicity, it is the "side effects" of impaired 
RNA and protein sythesis which are responsible for its 
therapeutic success, in that deprived of the ability to 
synthesize and enrobe themselves in HCG, the tumor cells 
are susceptible to immunologic attack. Clearly, as allogenic 
cells, they would be even more susceptible to host defences 
than an ordinary syngenically derived malignancy. Perhaps 
in following HCG levels as a measure of chemotherapeutic 
success, we are observing a primary process, to be followed 
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by immunologic ceil kill, rather than the decreasing 
products of a dwindling cell population. 
Another finding which increased interest in the 
role of HCG as a local immunosuppressive was the discovery 
that the pre-implantation blastocyst itself produces 
substantial amounts of an HCG-like substance which coats 
its surface, as demonstrable by immunofluorescent staining 
techniques (Wiley, 1974). As the initial implantation 
of the blastocyst, unprotected by barrier tissues, is 
one of the most difficult aspects of the immunology of 
pregnancy to comprehend, this discovery was of particular 
interest. However, as HCG levels in the blood drop 
sharply in the last two trimesters of pregnancy, other 
mechanisms must doubtless be postulated. 
In the search for other substances unique to pregnancy 
with possible immunosuppressive effects, the Pregnancy Zone 
protein (PZ) came to light, though it has been espoused 
chiefly in Sweden. In 1959, O. Smithies at the University 
of Toronto observed in his exhaustive experiments with 
starch gel electrophoresis of serum proteins, the presence 
of a protein found only in the serum of pregnant women 
(Smithies, 1959). It was later shown to be a high molecular 
weight (359,000) alpha2 globulin, usually found in pregnancy, 
but also in females taking oral contraceptive agents and 
in men treated with estrogens for advanced prostatic 
carcinoma (Margolis and Kenrick, 1969* Cooper, 1963). 
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Unlike HCG, which tapers off in the last two trimesters of 
pregnancy, PZ, detectable first at approximately eight - 
weeks, continues to rise in concentration over the course 
of pregnancy, occasionally peaking the day following 
delivery, and then falling swiftly to undetectable levels 
(von Schoultz, 1974). 
The usefulness, if any, of the PZ protein is as yet 
unclear. It has been shown to be an immunosuppressive 
agent, inhibiting both PHA induced lymphocyte stimulation 
and the mixed lymphocyte reaction (von Schoultz et al, 1973 • 
Damber et al, 1975). 
In the normal pregnancy, PZP is detectable in 25% 
of cases tested in gestation weeks 7-8 and in 88% tested 
in weeks 17-18. Two thirds of all spontaneous abortions 
occuring after pregnancy has been detected occur between 
weeks 9 and 12, and studies show that a woman with 
undetectable levels of PZP during this period of time runs 
a risk of spontaneous abortion thirty times as great as 
those exhibiting normal levels (Beckman, Beckman, et al, 
1974). Other studies show a significant correlation between 
birthweight and PZP levels at term, however, no correlations 
are demonstrable between PZP levels and gestational age, 
placental weight, maternal age, parity, or previous abortion 
(von Schoultz, et al, 1974). 
The authors of the above study interpreted their 
findings to mean that the production of PZP was dependent 
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cells for approximately eight hours, effective antibody 
supression would not occur. This suggested a more complicated 
mechanism than simple B cell suppression, and B-T cell inter¬ 
actions, in the form of inactivation of a helper T cell 
population or the activation of a suppressor T cell popula¬ 
tion were proposed. 
In addition to mechanical and immunosuppressive 
regulators of maternal immune response, there are certain 
more purely "immunologic" mechanisms which have been 
theorized to explain the apparent lack of interaction 
between mother and feto-placental unit. The literature 
is complex and contradictory? a good number of ideas 
previously accepted have been shown to be invalid, but 
will be mentioned for historical interest. 
As early as 1924, Little hypothesized that the 
conceptus was antigenically immature and hence not recog¬ 
nized as foreign by the mother, a supposition based on 
faulty work of the day. Interestingly, he also remarked 
on the apparent immunologic incompetence of the fetus 
during early pregnancy, an idea which continues to be 
accepted. The concept of fetal antigenic immaturity has 
been disproved by thousands of experiments since 1924, 
perhaps most simply by Woodruff in 1958 by the elicitation 
of a prompt immune reaction on the injection of its own 
fetal tissues into the flank of a pregnant mouse. 
For a time, the uterus was felt to be an immunolo- 
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gically "privileged site", invulnerable to attack. However, 
the common occurrence of ectopic pregnancies intraperitoneally 
in the absence of decidual formation makes this highly 
unlikely. 
The question of the antigenicity of the trophoblast 
is key in assessing maternal immune response to the feto¬ 
placental unit. As discussed previously, there may be 
various physical barriers separating trophoblast from 
endometrial tissue. However, there is much evidence to 
suggest that, at least at times, the trophoblast is highly 
antigenic. 
Hakansson et al, 1975, demonstrated the presence of 
parental H-2 antigens on the surface of pre-implantation 
blastocysts, and their disappearance after the onset of 
implantation. Anti-blastocyst and anti-placental sera have 
been shown to visualize separately on the pre-implantation 
mouse conceptus, implying the existence of various stage 
specific, embryo specific, and syncytiotrophoblast specific 
antigen expressions during development (Wiley and Calarco, 
1975). 
Billington et al, 1977, visualized antigen loss during 
early trophoblast differentiation, while the inner cell mass 
was perceived to remain antigenic. At a later stage of 
development, Faulk et al, 1977 demonstrated no HLA antigens 
persisting on trophoblast, but instead their concentration 
on the stroma of the chorionic villi. A theory whereby 
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grafts, applied to the mother, by IgG of placental origin. 
Bernard, et al, 1977, demonstrated the presence of maternal 
immunoglobulins on the blastocyst at the time of implanta¬ 
tion, in the uterine glands, on the trophoblast surface 
in increasing amounts over the course of the pregnancy, 
and coating the cells of the decidua and appearing as 
cytoplasmic granules therein. Acid elution of placenta 
was productive of an IgG capable of producing a blocking 
effect on the Mixed Lymphocyte Reaction (Revillard et al, 1976). 
The invocation of a blocking antibody also seems to yield 
an explanation for the aforementioned enhancement of renal 
allografts in passively immunized hosts. 
Blocking antibody may also be important in the preven¬ 
tion of graft-versus-host disease or runt disease. GVH is 
most commonly seen in the recipients of bone marrow trans¬ 
plants when the alien lymphocytes attack the host, which 
they perceive as non-self, producing a clinical picture of 
skin rash, GI disturbances, liver dysfunction and defects 
in cellular immunity with infection. However, with refer¬ 
ence to reproduction, GVH disease is characterized by the 
severe runting and subsequent death of young born under 
certain experimental, and perhaps occasionally natural, 
conditions. Beer and Billingham were successful in pro¬ 
ducing GVH disease experimentally in in young produced in 
four mating experiments? syngenic matings in which the 
mother was immunosuppressed and injected with foreign 
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cytes which on re-exposure to the antigen (or on occasion, 
to other non-specific antigens) produce direct cytotoxicity 
or attract via release of lymphokines, other types of cells 
and produce an inflammatory reaction. An example of a Type 
IV reaction is the PPD, Non reaction in the presence of 
known infection can indicate anergy, a condition associated 
with certain infections, tumors, and on occasion, pregnancy. 
In the laboratory. Type IV, or "cell mediated" reactions can 
bfee evaluated by the Mixed Lymphocyte Reaction, in which 
lymphocytes from two sources react to each others presence 
by the production of DNA. 
It is the Type IV reaction which is thought to be 
responsible for allograft rejection, though all types 
undoubtedly are active to some extent. An example related 
to pregnancy of the role of the T cell was the demonstration 
of prolonged survival of implanting rat blastocysts in 
athymic mice (Hcikansson et al, 1977 ). 
Thus, the concept of a "blocking antibody" is very 
appealing for application to the immunologic paradox of 
pregnancy. An antibody which could mask crucial histocompat¬ 
ibility antigens would have the dual advantages of preventing 
attack by both the humoral and cell mediated systems, and 
preventing the formation of colonies of sensitized lymphocytes. 
An in vivo search for candidates which might be blocking 
antibodies was successful. In 1974, Voisin and Chouat 
demonstrated the enhancement of paternal origin skin alio- 
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nodes, which drain the uterus, in the mother prior to 
pregnancy. This observation, along with passive transf-er 
studies, led to the suspicion that a humoral antibody was 
the principle effector of this protective maternalinfLuenason 
placental growth, conceivable a "blocking antibody". 
At this point, perhaps a brief review of various types 
of immune response applicable to allograft rejection, and 
a summary of certain inhibitory factors is in order. 
In Type I reactions, circulating antibody (IgE) binds 
antigenic determinants on the cell membrane as well as 
basophils or mast cells, causing release of vasoactive 
amines. In Type II reactions, circulating IgG or IgM 
binds to antigenic determinants on the cell membrane, 
leading to complement fixation and target cell destruction 
In cases where complement fixation does not occur, IgG 
may function as a so called "blocking antibody", attaching 
to the antigen and masking it, preventing its attack by 
cytotoxic antibodies or lymphocytes. In so called "anti¬ 
body-dependent cell mediated cytotoxicity", cell kill 
depends on the presence of both antibody and non-T non-B 
lymphocytes or null cells. In Type III reactions, the 
deposition of antigen-antibody complexes in the tissues 
lead to cell damage at the site of deposition via complement, 
and the release of lysozomal enzymes, vasoactive amines, etc. 
In Type IV reactions, previous antigen exposure is respon¬ 
sible for the production of colonies of sensitized lympho- 
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It has long been known that outbred rodents tend to 
produce larger litters with heavier feto-placental units, 
quite opposite to what one might expect invoking the 
possibility of immunologic attack by the mother. The 
reasons for this were completely obscure until a series 
of experiments were performed by Beer and Billingham, 
leaders in the field of the immunology of pregnancy. 
Th&yi found that the presensitization of the rat uterus 
with paternal cells or washed sperm could engender a 
markedly increased "flare" reaction in the endometrium 
when it was re-exposed to paternal antigens in the form 
of the blastocyst. Far from decreasing fertility, more 
implantations were noted, each productive of a heavier 
conceptus. It was postulated that increased vascularity 
of the site of implantation led to increased penetration 
of the trophoblast and a larger placenta (Beer and Billing¬ 
ham, 1974 ) or tbcfciraternal antigens ntnmulsted placental cell growth (GVH reaction). 
Further experiments demonstrated that, though larger 
placentas were produced by allogenic fetuses than by 
syngenic fetuses, this difference could be enhanced by 
the presensitization of the mother to paternal antigens, 
and reduced by the induction of tolerance to paternal 
antigens (Beer etu.al; 19751_ , ” 5 .- 
Interestingly, it was noted that the "advantages" of 
outbreeding (as measured by feto-placental weight) could 
be much reduced by the excision of the para-aortic lymph 
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antigens might be polarized on the fetal side of individual 
cells was proposed. 
Low levels of both HLA-A and HLA-B antigens (approx¬ 
imately 5% of levels detected on lymphocytes) were noted 
in mid-gestation by Goodfellow et al, 1976. 
Secondary evidence of the antigenicity of the tropho¬ 
blast exists in that anti-HLA antibodies are produced in 
response to hydatifozmmole pregnancies comprised only of 
trophoblastic tissues (Lawler, 1974). Both normal pregnancies 
and ectoplacental cone implants have long been known to 
stimulate local lymphadenopathy in the draining nodes. 
Finally, the production of antibodies directed against 
the trophoblast has been documented. Their presence and 
their possible contribution to the decreased perceived 
antigenicity of the trophoblast will be discussed below. 
Curiously, there is much evidence to suggest that 
fetal genetic disparity may exert a beneficial influence 
on the development of the conceptus. In the many experi¬ 
mental attempts to jeopardize the conceptus by the induction 
of transplantation immunity to parental antigens, there 
have been numerous failures (Lanman et al, 1962 ) and only 
the occasional success (Breyere and Springer, 1969), in this case 
demonstrating decreased litter size in mothers previously 
sensitized to paternally derived sarcoma cells. The pheno¬ 
menon of enhanced renal allograft survival in passively 
immunized hosts has long been appreciated but not understood. 
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on a healthy conceptus. However, the data are equally 
consistent with PZP as being necessary for a healthy 
conceptus and the prevention of abortion. Unfortunately, 
there has been no further work in this field which sheds 
light of the question of the role of the PZP or the 
mechanism of its production. 
Another possible immunosuppressive agent associated 
with pregnancy is alpha fetoproteir (AFP). A major 
constituent of amniotic fluid, it is produced by the 
fetal liver in large quantities during embryogenesis, 
levels peaking in early-mid gestation, dropping linearly 
with approaching birth,,and falling to extremely low 
levels after birth which are maintained during adulthood 
except for certain neoplasms and diseases involving areas 
of regeneration in the liver. In the laboratory, AFP 
has been shown to inhibit both primary and secondary 
antibody response (Murgita and Tomasi, 1975a) as well as 
the mixed lymphocyte reaction and mitogen-induced lymphocvte 
transformation (Murgita and Tomasi, 1975b). Obviously, 
the timing of the appearance of AFP and its reappearance 
in cases of malignancy make it an appealing candidate for 
an immunosuppressant in both cases. 
Interestingly, it was found that the timing of addition 
of AFP to antigen stimulated antibody producing cell cultures 
was vital. Were the AFP not added to the cultures early in 
the stimulation process and allowed to incubate with the 
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lymphocytes, syngenlc matings in which the mother received 
foreign lymphocytes specifically sensitized against her- 
strain, allogenic matings in which the mother received 
lymphocytes sensitized against the paternal strain, and 
in allogenic matings in which the mother was presensitized 
to paternal antigens via skin grafts. It was noted, however, 
that the results of this last experiment were time dependent— 
that if matings occured more than two weeks following graft 
attempts, GVH disease did not develop in the young. Similarly, 
had a mating occured before grafting attempts, GVH disease 
could not subsequently be produced in the young of any 
mating. This seemed to indicate the time-dependent develop¬ 
ment of a blocking antibody protective against the develop¬ 
ment of GVH disease (Beer and Billingham, 1975). In light 
of the fact that GVH disease is almost unknown in "unadulter¬ 
ated" pregnancies, although there is good evidence for the 
exchange between mother and fetus of leukocytes both during 
pregnancy and at delivery (Gill, 1977), it seems likely that 
similar factors are at work during normal gestation. 
Various other mechanisms of "enhancement" or immune 
mediated suppression of graft rejection have been proposed. 
The importance of antigen-antibody complexes in the inhib¬ 
ition of in vitro cytotoxicity has been investigated, employ¬ 
ing a number of experimental models. In a tumor model of 
enhancement, sera from mice carrying viral-induced sarcomas 
were shown to block the cytotoxic effect of lymphocytes 
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immune to the tumor-specific antigens of the neoplasms. 
By absorption onto tumor cells and subsequent elution, -two 
fractions were recovered, neither of which alone had any 
blocking effects. However, a 1:1 mixture of the two fractions 
demonstrated blocking, as did the lower molecular weight 
fraction if incubated with target cells and lymphocytes, 
data very suggestive that an antigen-antibody complex was 
the active factor in the blocking activity,(Sjogren, et al, 
1971). Later work by the same group revealed that the 
higher molecular weight portion contained IgG, while the 
lower did not, was presumed to be antigen, and was presumed 
to have its activity dependent on interaction with effector 
lymphocytes. 
A similar study involving liver allograft rejection 
demonstrated prolongation of survival with the administration 
at equivalence of alloantigen and antibody raised against 
the alloantigen (Myburgh and Smit, 1975). 
Another candidate for the inhibition of cell-mediated 
and/or humoral immune response is the "suppressor T cell". 
Again, in studies plucked from organ transplantation 
literature in the absence of experiments involving gesta¬ 
tion, Jirsch et al, 1974 demonstrated increased cardiac 
allograft survival in mice treated with lymph node cells 
from tolerant mice, in the absence of transferred serum 
factors. Kilshaw et al, 1975 demonstrated a similar 
transfer of tolerance via spleen cells. T cells were 
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From the experiments presented in the first section 
of this paper, it may be appreciated that immunologic 
factors play an important and, to some extent, unappreciated 
role in normal and abnormal pregnancy. Certain parallels 
can be drawn between possible malfunctions of the proposed 
mechanisms and known disease states encountered in preg¬ 
nancy. There is now reason to believe that in some cases, 
infertility, spontaneous abortion, herpes gestationis, 
toxemia, and pregnancy associated disseminated intravascular 
coagulation may have immunologic causes. These will be 
discussed, with reference to possible therapeutic modalities 
directed at the immune response. 
As discussed previously, the pregnant human female 
is not well suited to experimental intervention and the 
greater part of the work in this field relies on "experiments 
of nature", mouse studies, retrospection, and pure theory. 
Finally, a short discussion of the major histocompat¬ 
ibility complex with reference to ontogeny and phylogeny 
will be presented. 
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Infertility and Spontaneous Abortion 
In the clinical evaluation of the patient with primary 
infertility, procedures are undertaken to assess functioning 
of the various steps necessary for the successful initiation 
of a pregnancy—hormonal studies to establish ovulatory 
function, evaluations of sperm number and motility, patency 
of the Fallopian tubes etc.—all points of possible 
breakdown, most amenable to attempts at therapeutic inter¬ 
vention. However, the standard infertility work-up reveals 
no recognizable cause in approximately 30% of patients 
(Dor et al, 1977). Because of the conceptus's tenuous 
position as allograft, it seems not unlikely that some of 
these reproductive failures may fall into the realm of 
the immunologist. 
Let us propose three types of infertility based on 
the immunlogic concepts discussed in the first part of 
this paper* first, the well known "anti-sperm antibody" 
theory which has been espoused by certain clinicians, 
though it has fallen out of favor recently, second, 
the failure of implantation due to immunologic destruction 
by the very inflamatory process necessary for nidation, 
third, abortion soon after implantation or at any step 
in gestation due to the inadequate production of "blocking 
antibodies" and the subsequent rejection of the conceptus, 
or to-theitrinabilityito overcome a particularly strong antigen 
or pre-existing antibody. Certain laboratory data support each. 
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presumed to be the vector as treatment with antitheta 
antibody and complement abolished the effect. 
Thus, there is reason to believe that many factors 
contribute to the success of the fetus as allograft; 
the sine qua non of immunosuppression does, however, 
seem to be the blocking antibody. 
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The "anti-sperm" antibody theory, which caused much 
excitement on its introduction, states that fertility may 
be impaired by the development in the female of immobilizing 
or sperm-agglutinating antibodies in response to sensitization 
by sperm introduced vaginally (Franklin and Dukes, 1964). 
It was shown that a higher percentage of women suffering 
from infertility of unknown cause had circulating antibodies 
to sperm (72%) than did fertile women (5.7%). Certain 
objections to this theory have been encountered. Other 
studies have failed to show the same high percentages of 
infertile women (Glass and Vaidya, 1970). Attempts aimed 
at contraception via the sensitization to sperm antigens 
by the parenteral route have been noticeably failures 
(Edwards, .1960), even though this route (Tyler et al, 1968) 
is far more effective than vaginal absorption in stimulating 
antibody response. studies ascertaining the percentage 
of infertile women with antibodies have used women of known 
fertility for controls, usually requiring at least two 
pregnancies. Though this seems to be done for obvious 
reasons, it prevents the possible association between 
pregnancy and decreased antibody. Were women who had 
avoided pregnancy by the consciencious use of, for example, 
birth control pills used as controls and estimated to be 
about 70% fertile, the possibility that "blocking antibodies" 
left over from a previous pregnancy prevented antigenic 




It has also been hypothesized that locally produced 
antibodies in the genital tract could prove spermicidal, 
and indeed, these can be shown to be produced (Lippes et 
al, 1970). However, the role of such antibodies remains 
obscure especially in light of the previously discussed 
data linking local sensitization with washed sperm to 
increased fertility and improved fetal growth withing the 
sensitized uterus. It may well be that the antibodies 
detected by Lippes et al prove advantageous. 
In general, no conclusions have been reached regard¬ 
ing the deleterious nature of the anti-sperm antibodies. 
However, it is usual practice to prescribe an empiric 
trial of condom therapy (preventing female contact with 
sperm antigens) while monitoring anti-sperm antibody levels. 
This method has enjoyed some degree of success (Glass and 
Vaidya, 1970). 
Far less research has been devoted to the investigation 
of faulty implantation as a cause for infertility, probably 
because of the difficulty of these investigations in the 
human. It does not seem unreasonable that an initial 
"anaphylactic" contact with the uterine wall could prove 
destructive to the blastocyst. Furthermore, prior sensitization 
to paternal antigens, either via sensitization to blood 
group antigens or the aforementioned anti-sperm antibodies, 
could produce a secondary immune response at the site of 
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implantation vigorous enough to imperil the embryo. 
Naturally occurring antibodies such as the secretory anti¬ 
bodies against ABO determinants could also work at this 
stage. In the one existing study of implantation efficacy 
in the human, uterine scrapings were obtained from a typical 
gynecologic clinic population, some of whom complained 
of infertility. Careful examination of the scrapings 
revealed numerous persistant blastocysts which had failed 
to implant presumably because of the marked lymphocytic 
and plasma cell infiltrates in the nearby endometrium 
suggestive of an incompatibility response at the site 
of attempted nidation (Jorgensen, 1970). The precise 
reasons for the failure of implantation are, of course, 
obscure, and further study in the infertile population 
(rather difficult because of the possibility of inadvertent 
abortions) with attention to various antigenic systems 
is needed. 
The problem of infertility due to abortion—recognized 
or otherwise--must be separated from infertility due to 
faulty implantation. While it is possible to reduce 
implantation via the active or passive sensitization of the 
mother to paternal antigens, it is exceedingly difficult, 
if not impossible, to cause mothers to abort alien fetuses 
by sensitization against paternal antigens (Beer and Billing- 
ham, 1977). While the demise of the blastocyst may be 
seen as due to sensitization, with the development of cyto- 
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toxic antibodies and antigen-specific lymphocytes, the demise 
of the fetus may be considered as due to the lack, of sensi¬ 
tization, and hence the lack of production of sufficient 
amounts of the appropriate blocking antibodies to prevent 
attack by the immune system or any pre-existing antibodies. 
The amount of blocking antibody required to maintain a 
pregnancy might be assumed to be proportional to the degree 
of genetic disparity between mother and fetus, and in cases 
of extreme disparity, this mechanism might prove insufficient, 
resulting in abortion. The histopathology of the chromosomally 
normal abortus usually reveals focal areas of decidual necro¬ 
sis with an intense inflammatory infiltrate suggestive of 
a rejection phenomenon; it is however, difficult to say 
whether this represents a primary phenomenon or a secondary 
reaction to a conceptus which has succumbed to one of the 
many non-immunologic, non-chromosomal causes of abortion 
in each individual case (Robbins, 1974). 
That naturally occurring or previously acquired antibody 
may be harmful to the conceptus can be demonstrated by 
Rh and ABO incompatibility, both of which may damage the 
fetus. The important difference between these two systems 
is that ABO antibodies, which occur naturally, may damage 
the first pregnancy, while Rh sensitization affects further 
pregnancies. The deleterious effects of Rh sensitization 
are known to all; fewer realize the impact of the ABO system 
on fertility. In a study of karyotypically normal abortuses 
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of the first 16 weeks of pregnancy, it was shown that a 
significantly higher incidence of ABO incompatibility 
between mother and fetus was present than in karyotypically 
abnormal "controls” (Lauritsen et al, 1975), the maximum 
fraction of abortions for which ABO incompatibility might 
be responsible being 18%. Other studies (Tyler et al, 1967; 
Behrman et al, 1960) have noted the high frequency of ABO 
incompatibility in the population of physiologically normal 
infertile couples. 
The role of HLA incompatibility in infertility and 
spontaneous abortion is as yet poorly defined. Mittal, 1975, 
demonstrated no decrease in pregnancies or offspring in 
HLA incompatible couples. In another study, twenty-nine 
couples with spontaneous abortions were evaluated according 
to the number of HLA-A and HLA-B antigens which the parents 
had in common and compared to couples with a successful 
pregnancy and no abortion history. 59% of the parents 
of the abortuses shared none of the possible two HLA-A 
antigens, while 37% of controls shared none. Although 
these results were not statistically significant, they 
are intriguing and certainly bear repetition with a larger 
series (Lauritsen et al, 1976). Anti-HLA blocking activity 
has been noted in serum. Its significance is unknown (Jeennetetal,J977). 
The role of the immune system in the 54% (Kajii et al, 1973) 
of abortuses which are chromosomally abnormal is unexplored. 
Many of these fetuses are physiological ly or Hochsmically tnf.it ar3 
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succumb for reasons of their own. However, certain karyo¬ 
types which are potentially viable (eg. trisomy 21) are 
heavily represented in the spontaneously aborted population. 
Indeed, only one in five Downs'; syndrome fetuses survives 
to birth. Although this phenomenon could certainly repre¬ 
sent a spectrum of viability, it is perhaps worth consider¬ 
ing whether the karyotypically abnormal fetus could be 
recognized as such and immunologically discarded. For this 
rather unlikely hypothesis to be true, antigenic incompat¬ 
ibility would have to be capable of causing abortion (as 
discussed above) and chromosomal aberrancy would have to 
affect surface antigens displayed by the cells. There is 
no evidence that the latter is the case, except in cases 
where a defect in the histocompatibility locus is involved. 
However, there is also no evidence that it is not the case 
and as chromosomal abnormalities may cause defects in 
protein and enzyme synthesis, the idea that surface antigens 
could be affected is not unthinkable. Whether they could 
be changed enough to over-ride the preservative influence 
of the blocking antibodies is another question. 
Interestingly, though rather off the subject, embryos 
with deletions in the T locus (located on chromosome 17 
next to the major histocompatibility locus, similar in 
makeup, and thought to code for surface antigens necessary 
for cell-cell identification and interaction) cease growth 
at specific and predictable stages in development and might 
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be viewed as an example whereby the nascent fetal "immune 
system" was responsible for its own demise (Bennett, 1978). 
The effects of various immunosuppressive and immuno- 
stimulating agents on reproductive efficacy may also give 
some insight into the role of the immune system in the 
normal pregnancy. As noted previously, the mating of mice 
of two different strains tends to produce litters of more 
numerous offspring with larger feto-placental units. The 
reasons for this may be an increased decidual response 
caused by the genetically foreign material, leading to 
a larger placenta, and that leading to a Larger fetus, 
or a stimulation of the placental cells by the neighboring 
maternal cells and a resulting increased multiplication in 
what might be called a mild GVH reaction, also leading to 
a larger placenta. Cortisone acetate has been shown to 
delay or inhibit ovoimplantation in the rat, although 
this did not appear to be due to its anti-inflammatory 
activity as higher equivalent doses of non-steroidal 
anti-inflammatory agents (indomethacin, phenylbutazone, 
flufenamic acid) failed to have similar effects. These 
drugs were, however, noted to decrease decidual response 
resulting from uterine trauma. A central mechanism for 
the action of cortisone acetate was postulated (Bennett 
et al, 1977). 
In another study, allogenic matings were treated 
with one of three immunosuppressive or cytotoxic agents 
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(methylprednisolone, cyclophosphamide, azathioprine), one 
of three immunostimulants (B. pertussis, C. parvum, BCG), 
or saline control. Though no difference in number of 
implantations was noted, the immunostimulated group showed 
a trend toward larger feto-placental units and increased 
spleen and para-aortic node weight, while the immunosup- 
presive/cytotoxic group tended toward smaller feto-placental 
units and smaller spleens and para-aortic nodes. Azathip- 
prine resulted in 100% resorption of fetuses, cyclophos¬ 
phamide resulted in 50% resorption (Scott, 1977;). The most 
interesting finding in this study was that the cyclophos¬ 
phamide resorption rate could be corrected to normal (near 
zero) by the concommitant administration of the non-specific 
immunostimulant BCG, data completely consistent with the 
idea that immunostimulation, rather than immunosuppression 
is necessary for the maintenance of an allogenic pregnancy, 
conceivably to promote the production of blocking antibodies. 
The experiment would well be repeated using syngenic matings 
as controls. 
It must be remembered that the above experiments were 
performed using a system which did not suffer from infertility, 
and therefore any benefits (permitting implantation or 
preventing early abortion) which might accrue in certain 
circumstances would not be visualized. Therapeutics in 
human infertility is a difficult business as the precise 
diagnosis--whether infertility results from failure of 
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fertilization, failure of implantation, or unrecognized 
spontaneous abortion—is always in doubt. Condom therapy 
has been tried, possibly with some success, in certain 
cases of infertility; perhaps in others the intrauterine 
instillation of washed sperm could raise implantation rates 
as suggested in the animal model. It is also not unthinkable 
that in certain circumstances, short courses of immuno¬ 
suppressives or immunostimulants could be appropriate. 
The clinical experience with the immunologic management 
of infertility with pharmacologic agents is almost non¬ 
existent. shulman, et al, 1978 have used corticosteroids 
in male autoimmune infertility with some success, and in 
female, presumably "anti-sperm antibody" infertility 
with a lesser degree of success. Women on chronic immuno¬ 
suppressive therapy for transplantations or systemic 
disease have smaller feto-placental units than normals, 
however, the effects of their underlying disease on fetal 
growth is difficult to evaluate. In one case, a diseased 
"control" was available—a woman with end stage renal disease 
who received a transplant from a twin and thus required no 
immunosuppression. Her fetoplacental unit was of normal 
weight. (Scott, 1977) 
Obviously, a much greater understanding of immune 
infertility is needed before therapeutic trials become 
appropriate. However, it should be considered in the differ¬ 
ential of refractory infertility, and under certain circum- 
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stances, investigation of such parameters as ABO incompat¬ 




Herpes gestationis is a rare bullous disease occuring 
only during pregnancy or shortly post partum, usually 
beginning during the second trimester. It is characterized 
by a pruritic erythematous vesiculobullous eruption appearing 
on abdomer\ extremities and buttocks occasionally accompanied 
by systemic manifestations of malaise and fever, and striking 
eosindphilia. 
Immunologic and histologic investigation of the 
disease have demonstrated the presence of the so-called 
"HG" factor in the serum of affected patients, thought to 
be an IgG. This factor deposits in the basement membrane 
zone between the dermis and the epidermis causing complement 
fixation and cell damage, resulting in the eruption. (Jordon, 1576) 
HGF can cross the placenta and affect the fetus which 
may be born with a similar eruption. There is also an 
increased incidence of spontaneous abortion, stillbirth and 
prematurity among offspring (Lawley et al, 1978). 
Herpes gestationis tends to recur with subsequent 
pregnancies and with the use of estrogenic oral contraceptives. 
It generally responds to systemic high dose corticosteroids, 
and occasionally to local therapy. There is no correlation 
(contrary to what was once thought) with Rh sensitization or 
toxemia. 
As herpes gestationis is a disease associated with an 
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IgG found during pregnancy, it is tempting to build a case 
linking it to the production of blocking antibodies. 
Complement fixation may occur as the result of deposition 
of antigen-antibody complexes or the deposition of antibody 
alone. As HG can recur, with estrogenic stimulation, long 
after birth, when presumably no placental antigens are 
available, it seems possible that blocking antibody, specific 
for the basement membrane of the placenta, could cross react 
with the basement membrane zone in the skin and there 
activate the classical pathway of complement. Although 
complement fixing cytotoxicity does not occur in the pla¬ 
centa, antibodies can fix, or not fix complement depending 
on circumstances, and it is possible that in the placenta 
the abundant carbohydrate moieties on the surface prevent 
exposure for the reactions necessary. This possibility 
is consistent with the timing of disease--either in the 
second two trimesters when antibody levels presumably 
continue to rise, or with onset shortly after birth, when 
the sudden removal of the target cells would result in 
a temporary overload of the maternal circulation and 
increased opportunity for deposition. 
The telling experiment in this case is an easy one— 
the acid elution of a washed placenta from an affected mother, 
and the subsequent immunofluorescent staining of a skin 
biopsy obtained on clearing with the IgG gathered. Unfortun¬ 
ately, the disease is so rare a case might take years to find. 
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Toxemia of pregnancy and PIC 
A plethora of theories on the etiology of toxemia of 
pregnancy have been proposed. There is increasing evidence 
that this disease, characterized by edema, hypertension, 
proteinuria, and in its worst form, seizures, may well 
have an immunologic basis. 
Certain features of toxemia may be important in 
determining its etiology. It has been noted that the 
prevalence of toxemia is increased in the primagravida, 
multiple pregnancies and hydatiform molar pregnancies, 
in the diabetic, patients with previous hypertensive 
vascular disease, or previous renal disease. It progresses 
over the course of pregnancy and the definitive treatment 
is delivery of the placenta, aLthough toxemia may first 
appear an hour or so after delivery. The disease is 
frequently associated with poor fetal outcome. 
Histopathologically, toxemia is a diffuse disease 
effecting similar changes in many organs of the body. 
The vessels of brain, kidney, liver and placenta demonstrate 
the changes of vascular disease as well as fibrin and 
platelet deposition, intravascular coagulation. Peri¬ 
vascular hemorrhage and tissue edema are also seen? the 
lung may reveal pulmonary edema, intravascular coagulation 
and alveolar hemorrhagic diathesis similar to that 
encountered in endotoxic shock. The placenta shows 
multiple infarcts and trophobLastic degeneration. 
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The uteroplacental junction displays fibrinoid necrosis 
and narrowing of the spiral arteries in the decidua 
and similar changes in the uteroplacental arteries of 
the placental bed. The necrotic vessels harbor foamy 
lipophages, fibrin, macrophages,and thrombi and are 
surrounded by mononuclear infiltrates. (Robertson, 1975) 
These changes, known as atherosis, are similar to the 
pathology encountered in renal graft rejection. 
Thus, one theory of toxemia which may be supported 
by much evidence is that a deficiency in blocking antibody 
leads to damage of the placenta causing the release of 
certain substances which alone, or in combination with 
circulating antibodies may cause damage to the vasculature 
and a low grade disseminated intravascular coagulation 
syndrome. 
The evidence that toxemia may be touched off by a 
deficiency in blocking antibodies is strong. It is a 
disease almost exclusively of primagravidas, who, as men¬ 
tioned in the discussion of tolerance, would have had 
no opportunity to be presensitized to paternal antigens 
except via sperm. Interestingly, numerous exposures to 
paternal sperm prior to conception has been shown to 
decrease risk of toxemia (Marti and Herrmann, 1977). 
Prior blood transfusion also has a protective effect 
(Feeney et al, 1978). Toxemia in second pregnancies is 
far more common when a different father is involved 
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(Need, 1975). A decrease in anti-HLA antibodies below 
usual pregnancy levels has been noted (Jenkins et al, 1977). 
An increased blocking load is present in multiple pregnancies 
and molar pregnancies which frequently are associated with 
toxemia. 
Interestingly, except for certain anecdotal reports 
of toxemia in Rh incompatible pregnancies (Hirsch and 
Mark, 1964? Nicolay and Gainey, 1964), the disease does 
not seem to occur in cases of great antigenic challenge, 
rather, victims have increased maternal-fetal HLA compat¬ 
ibility over normal pregnancies and tend to have a depressed 
MLR between lymphocytes from maternal and cord blood 
(Jenkins et al, 1978). No difference is noted in the 
frequency of toxemia in monozygotic vs. dizygotic twins 
(Campbell et al, 1977) It is perhaps possible that fetuses 
lacking major histocompatibility complex differences fail 
to stimulate the production of blocking antibodies, yet 
are later rejected on the basis of other determinants. 
As mentioned above, the placenta in toxemia shows 
pathology characteristic of a rejection phenomenon. Evidence that 
placental damage is the second step in the production of 
toxemia is that; much in the fashion of the narrowed utero¬ 
placental arteries causing poor perfusion and infarcts, 
toxemia can experimentally be reproduced by partial ligation 
of the uterine artery (Hodari et al, 1967). it may be 
argued that placental infarction is secondary to vessel 
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disease caused by another mechanism? it is perhaps more 
likely that the process is a multiplying effect whereby 
placental damage leads (see below) to increased vessel 
damage, resulting in even poorer placental perfusion. 
Although the immunologic destruction of the placenta 
is equally consistent with a graft vs. host phenomenon, 
this mechanism seems unlikely in that mole pregnancies, 
containing no lymphoid tissue, are among the leaders in 
producing toxemia. 
Noting the lupus-like features of toxemia, it should 
not be surprising that the major immunopathological lesions 
are the presence of circulating immune complexes and their 
deposition in vessel walls and the renal glomeruli 
(Stirrat et al, 1978; Kitzmiller et al, 1973; Morris, 
et al, 1964) In the vessel, complex deposition and 
subsequent complement fixation can lead to endothelial 
damage, platelet aggregation, and the activation of the 
coagulation system; in the kidneys, damage to vessels 
and glomerular basement membranes can produce a decreasing 
GFR, proteinuria and hypertension on a poor perfusion or 
volume overload basis. There is evidence that immune 
complex deposition occurs to some extent even in normal 
pregnancies (Tung, 1974), and in the presence of pre¬ 
existing renal disease, the mechanism for clearance of 
the Ag-Ab complexes is faulty, they linger longer and 
incur more destruction, possibly explaining the increased 
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incidence of toxemia in patients with renal lesions. 
Similarly, it might be proposed that in patients with - 
pre-existing vascular disease (diabetics, hypertensives) 
previous vessel damage might predispose to the deposition 
of complexes and further destruction. 
The source of the antigens in the above model is 
presumably the placenta, perhaps increased antigen release 
stimulating the production of greater amounts of antibody 
and increasing amounts of the complex. Alternatively, 
the placenta's ability to dispose of complexes, turning 
them into innocuous substances could be overwhelmed, as 
suggested by Morisada et aL, 1976, leading to their dis¬ 
persal into the circulation, or soluble "blocking antigens" 
could be released by the placenta, disarming lymphocytes 
and combining with antibody, a variation on a theme 
proposed by Halle-Pannenko et al, 1976. There are few, 
if any animal models of toxemia, possibly because a 
hemochorial placenta, rare in animals, provides freer 
access to the maternal circulation for placental antigens. 
A subacute DIC picture plays an important part in 
the pathology characteristic of toxemia. Although there 
has been a certain amount of dissention (Condie, 1976) 
it seems clear that in toxemia the clotting parameters 
are suggestive of DIC (Bonner et al, 1971), In the 
infarcted placenta or the dead fetus, other factors, 
such as release of tissue thromboplastin undoubtedly 
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play a role. Indeed, a case has been reported of fetal 
demise being followed by severe DIC and subsequent severe 
toxemia (Imrie and Raper, 1977). Whether massive antigen 
release, tissue thromboplastin release, or both led to 
the toxemia is unclear. 
Indeed, resembling a giant hemangioma, the placenta 
may be a particularly vulnerable site for the initiation 
of a DIC-like process. There is evidence of increased 
fibrinolytic activity in the normal fetal circulation, 
(Foley et al, 1977) which may decrease in the toxemic 
pregnancy fetus (Condie, 1976). 
DIC or toxemia encountered post-partum may be due 
to the large transfer of antigenic blood components 
which occurs at partuition as documented by Gill, 1977. 
The lack of a "target organ" would assure abundant anti¬ 
body supply. 
A DIC picture associated with immunologic activity 
is reminiscent of thrombotic thrombocytopenic purpura, 
a disease of unclear etiology associated with lupus 
characterized by a microangiopathic anemia, thrombocyto¬ 
penia, renal damage and neurological symptoms, in which 
fibrin, gamma globulin and platelets deposit in and cause 
microthrombosis of heart, brain, kidney, pancreas and 
adrenal. It is interesting to speculate on a similar 
but autoimmune etiology. 
Previously, therapy for toxemia has been symptomatic 
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only, as well it might be as the etiology of this syndrome 
is just beginning to be elucidated. However, using the 
theory just presented, it is interesting to speculate on 
possible prophylaxis and treatment for toxemia. 
In the earliest stages, it might be feasible to attempt 
prophylaxis or treatment with immunostimulant agents, either 
paternal lymphocytes as suggested by Scott and Jenkins, 
1978, or non-specific immunostimulants such as BCG (which 
has not to date been shown to be teratogenic). Anticoag¬ 
ulation might be tried to prevent the low grade DIC picture, 
and in one case, warfarin was administered to a patient 
who had had two stillborn pregnancies complicated by 
severe toxemia. she remained normotensive until late 
pregnancy when the dtug was'stopped, atiwhieh time'her 
pressure rose within 24 hours. she delivered a normal 
child (Valentine and Baker, 1977) Warfarin was probably 
apoor choice because of the associated saddle-nose deformity, 
but heparin or an anti-platelet agent might be suitable. 
The use of steroids in late toxemia has not been 
espoused, though presented with tissue destruction initiated 
by antigen-antibody complexes, complement fixation and 
resulting inflamation, they seem the obvious choice. 
In glomerulonephritis, cortisone has been shown to inhibit 
the transit of immune complexes across vessel walls, hence 
preventing glomerular injury and inflamation (Germuth et al, 
1968). 

A caveat in the use of steroids is that they may 
significantly decrease antibody production--obviously 
undesirable in early toxemia as a deficiency in blocking 
antibody may be the root of the problem. Also, because 
of the kinetics of antigen-antibody interaction, a 
decrease in antibody may actually lead to an increase 
in Ag-Ab complexes as the two species approach equivalence. 
This could conceivable Lead to further destruction. 
(This reasoning could even be used to explain, primarily, 
why decreased antibody production could lead to toxemia, 
without invoking placental destruction from an immune 
reaction. However, it is more likely that steroids could 
be of some benefit in late stage disease when complexes 
threatened massive end organ damage, and could conceivably 
have the added benefit of minimizing any rejection reactions 
directed against the placenta. Interestingly, toxemia is 
associated with decreased serum cortisol levels compared 
with normal pregnancy (Galvao-Teles and Burke, 1973). 
There have been few studies on the effects of cortico¬ 
steroids on pregnancy, and none not complicated by underlying 
disease in the subject. However, in a study of 34 patients 
receiving corticosteroids for various reasons, including 
some patients with pre-existing renal disease, only one 
case of elevated blood pressure was noted (Warre.ll and Tay¬ 
lor, .1968). Further studies are needed to define the 
possible therapeutic role of steroids in toxemia. One can 

well imagine the hesitation of the clinician to treat 
an edematous and hypertensive patient with a drug having 
some degree of mineralocorticoid activity. 
Finally, in cases of toxemia severe enough to require 
delivery or interruption of pregnancy, an investigation 
of which techniques of delivery and abortion result in 
the least antigen load to the mother could be useful in 
the prevention of post-partum toxemia and DIC. 
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Teleology and the Histocompatibility Antigens 
In addition to the obvious advantages of self/non-self 
recognition in infection and tumor invasion, the MHC may, 
with a certain amount of teleologic reasoning, be perceived 
to provide other benefits to the future of the species via 
the mechanisms of gestation. Genetic disparity, heterozygo¬ 
sity and the avoidance of the production of double recessives 
in consanguineous matings are evolutionarily beneficial. 
The previously discussed tolerance phenomenon, whereby 
conceptuses genetically disparate from both mother and pre¬ 
vious conceptuses enjoy improved survival and growth, may 
play an important role in achieving these desirable ends. 
This phenomenon has been noted in sex order studies (Vernier, 
1977). Primiparas tend to have enhanced survival of male 
conceptuses, genetically disparate with regard to H-Y 
antigens from the mother, while in subsequent pregnancies 
fetuses of the sex opposite to that of the previous preg¬ 
nancy are favored. 
As mentioned previously, it is possible that other 
mechanisms exist to weed out the genetically unfit conceptus, 
the immune system patrolling the uterus for the extremely 
deviant fetus. It is interesting to speculate if the aging 
immune system in older mothers (demonstrated in mice by 
decreased responsiveness to PHA stimulation and tumor cell 
challenge (Perkins and Cacheiro, 1977) might be involved in 
the increased numbers of genetically anomalous infants born. 
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Finally, self-exposure to the MHC during development 
of the fetal immune system may be vital in establishing 
the knowledge of "self" and preventing autoimmune phenomena, 
as may be seen in tetraparental allophenic mice in which 
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